Aiolos Engineering Corporation company information, Employees & Contact Information

C4 takes the Ikaros/Aiolos battle to Bristol | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

GSK enters agreement to acquire Aiolos Bio GSK

PBK/TOPK mediates Ikaros, Aiolos and CTCF displacement from mitotic chromosomes and alters chromatin accessibility at selected C2H2-zinc finger protein binding sites Nature

Aiolos: a molecular guardian of type 2 innate immune cell residency and response ScienceDirect.com

Disease-associated AIOLOS variants lead to immune deficiency/dysregulation by haploinsufficiency and redefine AIOLOS functional domains JCI.org

Aiolos Bio raises $245M on prospect of better asthma drug BioPharma Dive

GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug statnews.com

AIOLOS Variants Causing Immunodeficiency in Human and Mice Frontiers

GSK concludes Aiolos Bio acquisition for up to $1.4bn Pharmaceutical Technology

GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal Reuters

GSK pounces on new start-up Aiolos to add anti-TSLP to pipeline FirstWord Pharma

Aiolos Bio launches with $245M Series A, chasing one of asthma’s hottest targets Endpoints News

GSK, moving fast to buy Aiolos, pays $1B to challenge Amgen, AstraZeneca for asthma market Fierce Biotech

GSK completes acquisition of Aiolos Bio GSK

The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes Nature

GSK to buy asthma drug startup Aiolos for $1B BioPharma Dive

Aiolos team reunites with $411M for new biotech with obesity drugs from China Endpoints News

IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development Nature

A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS Nature

T cell cytotoxic programming via reciprocal regulation of T Nature

Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody Business Wire

Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med Fierce Biotech

When mad AIOLOS drags IKAROS down: A novel pathogenic mechanism EurekAlert!

Aiolos Bio debuts with $245 million financing The Pharma Letter

GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline BioSpace

Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments Business Wire

Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity Nature

Aiolos Bio Launches With $245M As Asthma-Focused Funding Accelerates Crunchbase News

Aiolos debuts with $245 million to advance twice-yearly antibody for asthma FirstWord Pharma

GSK completes acquisition of Aiolos Bio for up to $1.4 bln Reuters

Aiolos Promotes Anchorage Independence by Silencing p66Shc Transcription in Cancer Cells ScienceDirect.com

GSK to Buy Respiratory Drug Developer Aiolos Bio CHEManager

GSK to expand respiratory pipeline with $1.4bn Aiolos Bio acquisition PMLiVE

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos ACS Publications

GSK acquires asthma specialist Aiolos Bio in $1.4bn deal This is Money

Immortals Fenyx Rising guide: Aiolos’s Strength Vault of Tartaros walkthrough and puzzle solutions Polygon

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4 | Blood Cancer Journal Nature

Immortals Fenyx Rising Blurry Vision Guide - How To Open The Red Door And Get Aiolos' Jar In The One-Eyed Giant TheGamer

Global Wind Day Gala and AIOLOS Awards ΕΛΕΤΑΕΝ

London: GSK to pay up to US$1.4bn for Aiolos Bio Investors in Healthcare

Aiolos Kenteris High Speed Ferry Auction Draws Zero Bids Argophilia Travel News

Astro Toy - Myth Cloth EX Sagittarius Aiolos Anime News Network